Menu
15 kids Halloween super hero costumes

15 kids Halloween super hero costum…

Is it a bird? Is it a pla...

FR's Chili Pepper Periodic Table

FR's Chili Pepper Periodic Table

If you think your chili p...

Southern food's provocative voice

Southern food's provocative voice

Like the South itself, Jo...

Friday 13th Facts and History

Friday 13th Facts and History

Long considered a harbing...

Regarding responsible fishing

Regarding responsible fishing

There are so many more fi...

Marketing new album releases

Marketing new album releases

For the music industry, t...

DIY Halloween costumes ideas

DIY Halloween costumes ideas

Looking for something hil...

Five flu fighting foods

Five flu fighting foods

Getting the flu is object...

Prev Next
Restaurant lunch highlights:

'Startling' cancer therapy results

'Startling' cancer therapy results

The 86 cancer patients were a disparate group, with tumors of the pancreas, prostate, uterus or bone. One woman had a cancer so rare there were no tested treatments. She was told to get her affairs in order.

All the patients carried genetic mutations that disrupted the ability of cells to fix damaged DNA. And all were enrolled in a trial of a drug that helps the immune system attack tumors.

The results, published on Thursday in the journal Science, are so striking that the Food and Drug Administration already has approved the drug,
Just 4 percent of cancer patients have the type of genetic aberration susceptible to pembrolizumab. But that adds up to a lot of patients: as many as 60,000 each year in the United States alone, the study's investigators estimated.

As reported on the New York Times website - READ MORE

Last modified onWednesday, 14 June 2017 05:56
back to top